Related references
Note: Only part of the references are listed.IL33 activates CD8+T and NK cells through MyD88 pathway to suppress the lung cancer cell growth in mice
Longsheng Xu et al.
BIOTECHNOLOGY LETTERS (2020)
Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells
Ying Yue et al.
CANCER SCIENCE (2020)
ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
John Alec Moral et al.
NATURE (2020)
An intrinsic role of IL-33 in Treg cell-mediated tumor immunoevasion
Aikaterini Hatzioannou et al.
NATURE IMMUNOLOGY (2020)
Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s
Marek Wagner et al.
CELL REPORTS (2020)
Interleukin-33 pretreatment promotes metastatic growth of murine melanoma by reducing the cytotoxic capacity of CD8+ T cells and enhancing regulatory T cells
Andra Jevtovic et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
IL-9 and IL-9-producing cells in tumor immunity
Jie Wan et al.
CELL COMMUNICATION AND SIGNALING (2020)
Interleukin-33 Induces the Enzyme Tryptophan Hydroxylase 1 to Promote Inflammatory Group 2 Innate Lymphoid Cell-Mediated Immunity
Anne-Laure Flamar et al.
IMMUNITY (2020)
Soluble ST2: A complex and diverse role in several diseases
Evgenija Homsak et al.
CLINICA CHIMICA ACTA (2020)
The IL-33/ST2 pathway suppresses murine colon cancer growth and metastasis by upregulating CD40 L signaling
Ping Luo et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
ST2 as checkpoint target for colorectal cancer immunotherapy
Kevin Van der Jeught et al.
JCI INSIGHT (2020)
Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling
Jimin Son et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Tumor-Derived IL33 Promotes Tissue-Resident CD8+ T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy
Lujun Chen et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Is There a Role for Basophils in Cancer?
Giancarlo Marone et al.
FRONTIERS IN IMMUNOLOGY (2020)
IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils
Melanie Kienzl et al.
ONCOIMMUNOLOGY (2020)
Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression
Sachiko Taniguchi et al.
SCIENCE (2020)
Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
Clemence Hollande et al.
NATURE IMMUNOLOGY (2019)
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer
Giuseppe Sammarco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
Eva Pastille et al.
MUCOSAL IMMUNOLOGY (2019)
Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model
Yulong Xia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing
Sara Andreone et al.
CANCERS (2019)
IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells
Ning Liu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
IL-33 Signaling Alters Regulatory T Cell Diversity in Support of Tumor Development
Amy Li et al.
CELL REPORTS (2019)
Bone marrow type 2 innate lymphoid cells: a local source of interleukin-5 in interleukin-33-driven eosinophilia
Kristina Johansson et al.
IMMUNOLOGY (2018)
Eosinophils: The unsung heroes in cancer?
Gilda Varricchi et al.
ONCOIMMUNOLOGY (2018)
A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33
Liang Ding et al.
CARCINOGENESIS (2018)
Characterization and allergic role of IL-33-induced neutrophil polarization
Bo Sun et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Plasticity of myeloid-derived suppressor cells in cancer
Evgenii Tcyganov et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
IL-33 Promotes the Development of Colorectal Cancer Through Inducing Tumor-Infiltrating ST2L+ Regulatory T Cells in Mice
Yaxing Zhou et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2018)
nterleukin-33 enhanced the migration and invasiveness of human lung cancer cells
Zhiping Yang et al.
ONCOTARGETS AND THERAPY (2018)
IL-33 notably inhibits the growth of colon cancer cells
Xuhui Chen et al.
ONCOLOGY LETTERS (2018)
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
Iryna Saranchova et al.
SCIENTIFIC REPORTS (2018)
Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ-Dependent Manner
Moritz F. Eissmann et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Biomarkers for Clinical Benefit of immune Checkpoint inhibitor Treatment-A Review From the Melanoma Perspective and Beyond
Kristina Buder-Bakhaya et al.
FRONTIERS IN IMMUNOLOGY (2018)
A network map of IL-33 signaling pathway
Sneha M. Pinto et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
The Role of IL-33/ST2 Pathway in Tumorigenesis
Kristen M. Larsen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2
Yongkui Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells
Jintong Chen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Damage-Associated Molecular Patterns in Inflammatory Diseases
Jong Seong Roh et al.
IMMUNE NETWORK (2018)
IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4(+) and CD8(+) T Cell Responses in Hepatocellular Carcinoma
Ziqi Jin et al.
JOURNAL OF IMMUNOLOGY (2018)
Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor Suppression
Alan Long et al.
JOURNAL OF IMMUNOLOGY (2018)
PD-1 Is Involved in the Dysregulation of Type 2 Innate Lymphoid Cells in a Murine Model of Obesity
Guillaume Oldenhove et al.
CELL REPORTS (2018)
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
Claudia Afferni et al.
FRONTIERS IN IMMUNOLOGY (2018)
Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis
Patrik Andersson et al.
JCI INSIGHT (2018)
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells
Ibrahim M. Sektioglu et al.
CANCER RESEARCH (2017)
IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Hui Xuan Lim et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
Donye Dominguez et al.
JOURNAL OF IMMUNOLOGY (2017)
TH9 cells in anti-tumor immunity
Thaiz Rivera Vargas et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Mechanisms involved in enhancement of matrix metalloproteinase-9 expression in macrophages by interleukin-33
Wataru Ariyoshi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
PD-1 regulates KLRG1+ group 2 innate lymphoid cells
Samuel Taylor et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer
Yujiang Fang et al.
MEDICAL ONCOLOGY (2017)
Wounds that heal and wounds that don't - The role of the IL-33/ST2 pathway in tissue repair and tumorigenesis
Neal L. Millar et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
Sandra M. Kallert et al.
NATURE COMMUNICATIONS (2017)
IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
Kailing Wang et al.
Oncotarget (2017)
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Marie-Helene Wasmer et al.
FRONTIERS IN IMMUNOLOGY (2017)
Are Mast Cells MASTers in Cancer?
Gilda Varricchi et al.
FRONTIERS IN IMMUNOLOGY (2017)
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
Valeria Lucarini et al.
ONCOIMMUNOLOGY (2017)
Epithelial-derived IL-33 promotes intestinal tumorigenesis in ApcMin/+mice
Zhengxiang He et al.
SCIENTIFIC REPORTS (2017)
IL-33-expanded human Vγ9Vδ2 T cells have anti-lymphoma effect in a mouse tumor model
Caroline Duault et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Cytokines in immunogenic cell death: Applications for cancer immunotherapy
Anne Showalter et al.
CYTOKINE (2017)
Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer
Maria Rosaria Galdiero et al.
FRONTIERS IN MEDICINE (2017)
IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment
Min Fang et al.
CANCER RESEARCH (2017)
IL-33 facilitates endocrine resistance of breast cancer by inducing cancer stem cell properties
Haiyan Hu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer
Charlotte O'Donnell et al.
BRITISH JOURNAL OF CANCER (2016)
Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
Xiaoguang Tong et al.
MOLECULAR ONCOLOGY (2016)
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
Kirsten D. Mertz et al.
ONCOIMMUNOLOGY (2016)
Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells
Peng Xiao et al.
ONCOIMMUNOLOGY (2016)
IL-33 signaling fuels outgrowth and metastasis of human lung cancer
Chunhong Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
ISOexpresso: a web-based platform for isoform-level expression analysis in human cancer
In Seok Yang et al.
BMC GENOMICS (2016)
Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells
M. S. Islam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis
Gianni Marone et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Interleukin-33 promoting Th1 lymphocyte differentiation dependents on IL-12
Mousa Komai-Koma et al.
IMMUNOBIOLOGY (2016)
IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis
Ankit Malik et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth
Juyang Kim et al.
JOURNAL OF IMMUNOLOGY (2016)
In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis
Jerome Biton et al.
JOURNAL OF IMMUNOLOGY (2016)
Alternative splicing of interleukin-33 and type 2 inflammation in asthma
Erin D. Gordon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Interleukin-33 enhances programmed oncosis of ST2L-positive low-metastatic cells in the tumour microenvironment of lung cancer
M. Akimoto et al.
CELL DEATH & DISEASE (2016)
The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages
Yunlong Yang et al.
NATURE COMMUNICATIONS (2016)
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment
Miho Akimoto et al.
NATURE COMMUNICATIONS (2016)
Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia
Lei Qin et al.
ONCOTARGET (2016)
IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF
Ralf Willebrand et al.
PLOS ONE (2016)
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
Iryna Saranchova et al.
SCIENTIFIC REPORTS (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The IL-33/ST2 axis augments effector T-cell responses during acute GVHD
Dawn K. Reichenbach et al.
BLOOD (2015)
The Association of Serum IL-33 and sST2 with Breast Cancer
Zhi-Ping Yang et al.
DISEASE MARKERS (2015)
IL-33 promotes innate IFN-γ production and modulates dendritic cell response in LCMV-induced hepatitis in mice
Yuejin Liang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
IL-33 Facilitates Oncogene-Induced Cholangiocarcinoma in Mice by an Interleukin-6-Sensitive Mechanism
Daisaku Yamada et al.
HEPATOLOGY (2015)
Emerging Functions of Amphiregulin in Orchestrating Immunity, Inflammation, and Tissue Repair
Dietmar M. W. Zaiss et al.
IMMUNITY (2015)
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
Ari B. Molofsky et al.
IMMUNITY (2015)
An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers
Hideaki Morita et al.
IMMUNITY (2015)
Cigarette Smoke Silences Innate Lymphoid Cell Function and Facilitates an Exacerbated Type I Interleukin-33-Dependent Response to Infection
Jennifer Kearley et al.
IMMUNITY (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
IL-33 Receptor ST2 Amplifies the Expansion of NK Cells and Enhances Host Defense during Mouse Cytomegalovirus Infection
Tsukasa Nabekura et al.
JOURNAL OF IMMUNOLOGY (2015)
New dog and new tricks: evolving roles for IL-33 in type 2 immunity
Jeremy M. Lott et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Circulating IL-33 level is associated with the progression of lung cancer
Myung Shin Kim et al.
LUNG CANCER (2015)
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
Rafael Carretero et al.
NATURE IMMUNOLOGY (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions
Laurel A. Monticelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
IL-33 activates tumor stroma to promote intestinal polyposis
Rebecca L. Maywald et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
Claudia Baumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
E. Suzanne u Cohen et al.
NATURE COMMUNICATIONS (2015)
Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
Xin Gao et al.
JOURNAL OF IMMUNOLOGY (2015)
IL-25-responsive, lineage-negative KLRG1hi cells are multipotential 'inflammatory' type 2 innate lymphoid cells
Yuefeng Huang et al.
NATURE IMMUNOLOGY (2015)
Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity
J. Y. Kim et al.
ONCOGENE (2015)
The brave new world of innate lymphoid cells
Gérard Eberl et al.
NATURE IMMUNOLOGY (2014)
Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue
Kazuya Ishikawa et al.
AURIS NASUS LARYNX (2014)
IL-33/ST2 pathway contributes to metastasis of human colorectal
Xuejian Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity
Daniel O. Villarreal et al.
CANCER RESEARCH (2014)
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
H. Inoue et al.
CELL DEATH AND DIFFERENTIATION (2014)
IgE and IL-33-mediated triggering of human basophils inhibits TLR4-induced monocyte activation
Felice Rivellese et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
The Transcription Factor GATA3 Is Critical for the Development of All IL-7Rα-Expressing Innate Lymphoid Cells
Ryoji Yagi et al.
IMMUNITY (2014)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): A novel therapeutic target for eosinophilic disorders
Fanny Legrand et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation
Jun Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
IL-33 Is an Unconventional Alarmin That Stimulates IL-2 Secretion by Dendritic Cells To Selectively Expand IL-33R/ST2+ Regulatory T Cells
Benjamin M. Matta et al.
JOURNAL OF IMMUNOLOGY (2014)
IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling
Wen-Ting Hu et al.
MOLECULAR HUMAN REPRODUCTION (2014)
IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice
R. Guabiraba et al.
MUCOSAL IMMUNOLOGY (2014)
Examining IL-33 expression in the cervix of HPV-infected patients: a preliminary study comparing IL-33 levels in different stages of disease and analyzing its potential association with IFN-γ
Lei Wang et al.
MEDICAL ONCOLOGY (2014)
Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells
Emma Lefrancais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Polarization of ILC2s in Peripheral Blood Might Contribute to Immunosuppressive Microenvironment in Patients with Gastric Cancer
Qingli Bie et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Significance of interleukin-33 and its relatec cytokines in patients with breast cancers
Jing Liu et al.
FRONTIERS IN IMMUNOLOGY (2014)
Serum IL-33 as a Diagnostic and Prognostic Marker in Nonsmall Cell Lung Cancer
Liang-An Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
Caterina Musolino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
Kun Gao et al.
CANCER LETTERS (2013)
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Dalia Burzyn et al.
CELL (2013)
Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor
Dietmar M. W. Zaiss et al.
IMMUNITY (2013)
Interleukin-33-Activated Dendritic Cells Induce the Production of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine
Masatsugu Kurokawa et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen
Lucia Gabriele et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
Su-Feng Chen et al.
JOURNAL OF PATHOLOGY (2013)
Potential autocrine regulation of interleukin-33/ST2 signaling of dendritic cells in allergic inflammation
Z. Su et al.
MUCOSAL IMMUNOLOGY (2013)
Structural insights into the interaction of IL-33 with its receptors
Xi Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TSLP Elicits IL-33-Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
Brian S. Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
Dominik Bergis et al.
TRANSLATIONAL ONCOLOGY (2013)
Innate lymphoid cells - a proposal for uniform nomenclature
Hergen Spits et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Oncosis: An important non-apoptotic mode of cell death
Priya Weerasinghe et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
The Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells
Jenny Mjosberg et al.
IMMUNITY (2012)
Identification of Innate IL-5-Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor Immunity
Masashi Ikutani et al.
JOURNAL OF IMMUNOLOGY (2012)
Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion
Irina G. Luzina et al.
JOURNAL OF IMMUNOLOGY (2012)
Novel Splice Variants of IL-33: Differential Expression in Normal and Transformed Cells
Hidetoshi Tsuda et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Prognostic Significance and Gene Expression Profiles of p53 Mutations in Microsatellite-Stable Stage III Colorectal Adenocarcinomas
Venkat R. Katkoori et al.
PLOS ONE (2012)
Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsiveness
Soo Mun Ngoi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Emma Lefrancais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
Weldy V. Bonilla et al.
SCIENCE (2012)
IL-33/ST2 axis in innate and acquired immunity to tumors
Ivan P. Jovanovic et al.
ONCOIMMUNOLOGY (2012)
Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members
Emma Lefrancais et al.
EUROPEAN CYTOKINE NETWORK (2012)
The Immune-Modulating Cytokine and Endogenous Alarmin Interleukin-33 Is Upregulated in Skin Exposed to Inflammatory UVB Radiation
Scott Napier Byrne et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Mast Cell 5-Lipoxygenase Activity Promotes Intestinal Polyposis in APCΔ468 Mice
Eric C. Cheon et al.
CANCER RESEARCH (2011)
Serum Interleukin-33 Levels in Patients with Gastric Cancer
Pinghu Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells
Qianting Yang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
IL-33-activated dendritic cells are critical for allergic airway inflammation
Anne-Gaelle Besnard et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
Ivan Jovanovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Identification of Constitutively Active Interleukin 33 (IL-33) Splice Variant
Jaewoo Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Dual Function Cytokine IL-33 Interacts with the Transcription Factor NF-κB To Dampen NF-κB-Stimulated Gene Transcription
Shafaqat Ali et al.
JOURNAL OF IMMUNOLOGY (2011)
Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
Jenny M. Mjosberg et al.
NATURE IMMUNOLOGY (2011)
IL-33 Induces IL-9 Production in Human CD4+ T Cells and Basophils
Lars Blom et al.
PLOS ONE (2011)
Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation
Shafaqat Ali et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS
Heth R. Turnquist et al.
BLOOD (2010)
Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
Sid P. Kerkar et al.
CANCER RESEARCH (2010)
IL-33 family members and asthma - bridging innate and adaptive immune responses
Clare M. Lloyd
CURRENT OPINION IN IMMUNOLOGY (2010)
IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation
Matthew R. Silver et al.
INFLAMMATION RESEARCH (2010)
T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses
Yibei Zhu et al.
JOURNAL OF IMMUNOLOGY (2010)
Human Eosinophils Exert TNF-α and Granzyme A-Mediated Tumoricidal Activity toward Colon Carcinoma Cells
Fanny Legrand et al.
JOURNAL OF IMMUNOLOGY (2010)
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Kazuyo Moro et al.
NATURE (2010)
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Daniel R. Neill et al.
NATURE (2010)
Systemically dispersed innate IL-13-expressing cells in type 2 immunity
April E. Price et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin
Theoharis C. Theoharides et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction
Nichole R. Blatner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Disease-associated functions of IL-33: the new kid in the IL-1 family
Foo Y. Liew et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33
Tatjana Pecaric-Petkovic et al.
BLOOD (2009)
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
Bharat B. Aggarwal et al.
CLINICAL CANCER RESEARCH (2009)
IL-33 promotes DC development in BM culture by triggering GM-CSF production
Nobuyasu Mayuzumi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production
Elvire Bourgeois et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Suppression of Interleukin-33 Bioactivity through Proteolysis by Apoptotic Caspases
Alexander U. Luethi et al.
IMMUNITY (2009)
IL-33-activated dendritic cells induce an atypical TH2-type response
Matthew A. Rank et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
The Essential Role of Single Ig IL-1 Molecule/Toll IL-1R8 in Regulation Immune Response
Katarzyna Bulek et al.
JOURNAL OF IMMUNOLOGY (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1
Corinne Cayrol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells
Liying Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The NLRP3 inflammasome: A sensor of immune danger signals
Suzanne L. Cassel et al.
SEMINARS IN IMMUNOLOGY (2009)
Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors-Insight into Heterotrimeric IL-1 Signaling Complexes
Andreas Lingel et al.
STRUCTURE (2009)
Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket
Lucie Roussel et al.
EMBO REPORTS (2008)
Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system
Yuichi Kondo et al.
INTERNATIONAL IMMUNOLOGY (2008)
IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Molly D. Smithgall et al.
INTERNATIONAL IMMUNOLOGY (2008)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-1β-driven ST2L express ion promotes maturation resistance in rapamycin-conditioned dendritic cells
Heth R. Turnquist et al.
JOURNAL OF IMMUNOLOGY (2008)
An IL-1 Cytokine Member, IL-33, Induces Human Basophil Activation via Its ST2 Receptor
Maho Suzukawa et al.
JOURNAL OF IMMUNOLOGY (2008)
CTLA-4: Negative regulator of the immune response and a target for cancer therapy
Ulrich Keilholz
JOURNAL OF IMMUNOTHERAPY (2008)
Inflammation: Gearing the journey to cancer
Joydeb Kumar Kundu et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
Mast cells are an essential hematopoietic component for polyp development
Elias Gounaris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IL-33 can promote survival, adhesion and cytokine production in human mast cells
Motoyasu Iikura et al.
LABORATORY INVESTIGATION (2007)
IL-33 and ST2 comprise a critical biomechanically induced and card ioprotective signaling system
Shoji Sanada et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Regulation of carcinogenesis by IL-5 and CCL11: A potential role for eosinophils in tumor immune surveillance
Ljubov Simson et al.
JOURNAL OF IMMUNOLOGY (2007)
IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo
Virginie Carriere et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Antibody targeted drugs as cancer therapeutics
D Schrama et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules
ES Baekkevold et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Expression and function of the ST2 gene in a murine model of allergic airway inflammation
K Oshikawa et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
